Comparison between Aptus Pharma IPO and Clear Secured IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Clear Secured IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aptus Pharma IPO | Clear Secured IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Market-Hub Stock Broking Pvt.Ltd. | Choice Equity Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the Clear Secured IPO is up to ₹81.31 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of Clear Secured IPO is ₹132.00 per share.
| Aptus Pharma IPO | Clear Secured IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹125.00 per share |
| Issue Price (Upper) | ₹70.00 per share | ₹132.00 per share |
| Issue Price (Final) | ₹70.00 per share | ₹132.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1000 shares |
| Fresh Issue Size | 17,66,000 shares | 61,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.36 Cr | up to ₹81.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,66,000 shares | 61,60,000 shares |
| Issue Size Total (Amount) | up to ₹12.36 Cr | up to ₹81.31 Cr |
Aptus Pharma IPO opens on Sep 23, 2025, while Clear Secured IPO opens on Dec 01, 2025. The closing date of Aptus Pharma IPO and Clear Secured IPO is Sep 25, 2025, and Dec 03, 2025, respectively.
| Aptus Pharma IPO | Clear Secured IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Nov 28, 2025 |
| Issue Open | Sep 23, 2025 | Dec 01, 2025 |
| Issue Close | Sep 25, 2025 | Dec 03, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Dec 04, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Dec 05, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Dec 05, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Dec 08, 2025 |
| Anchor Lockin End date 1 | Oct 26, 2025 | Jan 02, 2026 |
| Anchor Lockin End date 2 | Dec 25, 2025 | Mar 03, 2026 |
Aptus Pharma IPO P/E ratio is 11.29, as compared to Clear Secured IPO P/E ratio of 23.36.
| Aptus Pharma IPO | Clear Secured IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Clear Secured Services Ltd.'s revenue increased by 38% and profit after tax (PAT) dropped by 18% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.89 | 73.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.29 | 23.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹48.02 Cr. | ₹317.42 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.50% | 10.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.66% | 23.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.49 | 1.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.20 | ₹5.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 44.50% | 10.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in Clear Secured IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 12,32,000 shares in Clear Secured IPO.
| Aptus Pharma IPO | Clear Secured IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,28,000 shares | 18,48,000 shares |
| Market Maker Reservation | 94,000 shares | 3,25,000 shares |
| QIB | 3,52,000 shares | 12,32,000 shares |
| NII | 2,66,000 shares | 9,24,000 shares |
| RII | 6,20,000 shares | 21,56,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 17,66,000 shares | 61,60,000 shares |
Aptus Pharma IPO subscribed 22.27x in total, whereas Clear Secured IPO subscribed 8.83x.
| Aptus Pharma IPO | Clear Secured IPO | |
|---|---|---|
| QIB (times) | 1.24x | 9.98x |
| NII (times) | 28.75x | 12.51x |
| Big NII (times) | 30.64x | 14.66x |
| Small NII (times) | 24.93x | 8.20x |
| RII (times) | 31.43x | 6.60x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.27x | 8.83x |
